Related Experiment Video
Updated: Sep 26, 2026

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
Tumor necrosis factor-related apoptosis-inducing ligand gene on human colorectal cancer cell line HT29
Xiang-Ming Xu1, Chao He, Xiao-Tong Hu
1Department of Colorectal Surgery of the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China.
Aim:
To evaluate the therapeutic efficiency of Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) gene on human colorectal cancer cell line HT29.
Methods:
Human embryonal kidney cells transformed by introducing sheared fragments of Ad5 DNA (293 cell) were used for amplification of adenoviral vectors: Ad/GT-TRAIL,Ad/GT-Bax, Ad/GT-LacZ and Ad/PGK-GV16. Human colorectal cancer cell line HT29 was transfected with binary adenovirus-mediated TRAIL gene. Bax gene was used as positive control, LacZ gene was used as the vector control,and cells treated with PBS only were used as a mock control. The morphological changes, cell growth and apoptosis were measured by reversmicroscope, MTT method and flow cytometry.
Results:
All adenoviral vectors titer determined by optical absorbency at A260nm were 1X10(10) viral particle/ml(vp/ml). Obviously morphological changes of HT29 cells were observed when infected with Ad/GT-TRAIL, and these changes were much more obviously when Ad/PGK-GV16 was coinfected. The cell suppression percentage and the percentage of apoptotic cells were 52.5 % and 16.5 % respectively when infected with Ad/GT-TRAIL alone, while combining with Ad/PGK-GV16, the growth of HT29 was suppressed by 85.2 % and the percentage of apoptotic cells was 35.9 %. It showed a significantly enhanced therapeutic efficiency with binary system (P<0.05).
Conclusion:
A binary adenoviral vector system provides an effective approach to amplify viral vectors that express potentially toxic gene, TRAIL. Ad/GT-TRAIL showed a significantly enhanced therapeutic efficiency for HT29 when coinfected with Ad/PGK-GV16. Ad/GT-TRAIL could induce apoptosis of HT29 and inhibit its growth.
Insights
This study demonstrates that a binary adenoviral vector system effectively delivers the Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) gene to colorectal cancer cells. Co-infection with Ad/PGK-GV16 significantly enhanced TRAIL
Area of Science:
- Oncology
- Gene Therapy
- Molecular Biology
Background:
- Colorectal cancer (CRC) remains a significant global health challenge.
- Targeted gene therapy offers a promising avenue for CRC treatment.
- Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) is a potent inducer of apoptosis.
Purpose of the Study:
- To evaluate the therapeutic efficacy of the TRAIL gene delivered via an adenoviral vector in the human colorectal cancer cell line HT29.
- To assess the synergistic effect of a binary adenoviral vector system on TRAIL gene delivery and therapeutic outcomes.
Main Methods:
- Adenoviral vectors (Ad/GT-TRAIL, Ad/GT-Bax, Ad/GT-LacZ, Ad/PGK-GV16) were constructed and amplified.
- HT29 cells were transfected with Ad/GT-TRAIL, alone or in combination with Ad/PGK-GV16.
- Bax gene served as a positive control, LacZ as a vector control, and PBS as a mock control.
- Morphological changes, cell viability (MTT assay), and apoptosis (flow cytometry) were analyzed.
Main Results:
- Adenoviral vectors achieved a titer of 1X10(10) viral particles/ml.
- Ad/GT-TRAIL induced significant morphological changes and apoptosis in HT29 cells.
- Co-infection with Ad/PGK-GV16 markedly enhanced therapeutic efficiency, suppressing HT29 growth by 85.2% and increasing apoptosis to 35.9% (P<0.05).
Conclusions:
- A binary adenoviral vector system is effective for amplifying and delivering potentially toxic genes like TRAIL.
- Ad/GT-TRAIL, when co-administered with Ad/PGK-GV16, demonstrates significantly enhanced therapeutic efficiency against HT29 colorectal cancer cells.
- This binary system effectively induces apoptosis and inhibits the growth of HT29 cells, highlighting its therapeutic potential.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
lncRNA - Long Non-coding RNAs
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer
The Extrinsic Apoptotic Pathway

